Additional file 4: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

Qin, Xing; Guo, Haiyan; Wang, Xiaoning; Zhu, Xueqin; Yan, Ming; Wang, Xu; Xu, Qin; Shi, Jianbo; Lu, Eryi; Chen, Wantao; Zhang, Jianjun

doi:10.6084/m9.figshare.7587473.v1

13059_2018_1604_MOESM4_ESM.doc (86.5 kB)

Additional file 4: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

journal contribution

posted on 2019-01-14, 05:00 authored by Xing Qin, Haiyan Guo, Xiaoning Wang, Xueqin Zhu, Ming Yan, Xu Wang, Qin Xu, Jianbo Shi, Eryi Lu, Wantao Chen, Jianjun Zhang

Table S3. Relationship between tissue miR-196a level and clinicopathologic features in HNC; Table S4. Cox proportional hazards regression models for estimating overall survival related to Table S3. (DOC 86 kb)

Funding

National Natural Science Foundation of China

History

Usage metrics

Keywords

Exosome Cancer-associated fibroblasts miR-196a Cisplatin resistance Head and neck cancer CDKN1B ING5

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 4: of Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

Funding

National Natural Science Foundation of China

History

Usage metrics

Categories

Keywords

Licence

Exports